Ausgabe 8/2021
Inhalt (28 Artikel)
Role of lung and gut microbiota on lung cancer pathogenesis
Yue Zhao, Yuxia Liu, Shuang Li, Zhaoyun Peng, Xiantao Liu, Jun Chen, Xin Zheng
Aurora B kinase: a potential drug target for cancer therapy
Azaj Ahmed, Anas Shamsi, Taj Mohammad, Gulam Mustafa Hasan, Asimul Islam, Md. Imtaiyaz Hassan
Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence?
Abdul Arif Khan
Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer
Yu Zhang, Fei Wang, Hao-ran Sun, Ya-kai Huang, Jian-peng Gao, Hua Huang
Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation
Mohammed Alshalalfa, Hatem Abou-Ouf, Elai Davicioni, R. Jeffrey Karnes, Reda Alhajj, Tarek A. Bismar
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
Tilman D. Rachner, Sabine Kasimir-Bauer, Andy Goebel, Kati Erdmann, Oliver Hoffmann, Martina Rauner, Lorenz C. Hofbauer, Rainer Kimmig, Ann-Kathrin Bittner
The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer
Zhijun Shen, Chen Chen, Jianhai Sun, Jingsong Huang, Shiguo Liu
Testicular cancer follow-up costs in Germany from 2000 to 2015
Thomas Michaeli, Julia Michaeli, Daniel Michaeli
The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients
Jiebin Xie, Yueshan Pang, Xun Li, Xiaoting Wu
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma
Dorothee Hölzl, Georg Hutarew, Barbara Zellinger, Hans U. Schlicker, Christoph Schwartz, Peter A. Winkler, Karl Sotlar, Theo F. J. Kraus
Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling
Mariusz Bodzioch, Piotr Bajger, Urszula Foryś
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
Anna Ianza, A. Di Chicco, C. Biagi, F. Giudici, A. Dicorato, A. Guglielmi, F. Variola, S. Tomasi, G. Roviello, D. Generali, F. Zanconati
High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence
Mukta Basu, Amvrin Chatterjee, Balarko Chakraborty, Essha Chatterjee, Sabnam Ghosh, Sudip Samadder, Dilip Kumar Pal, Anup Roy, Jayanta Chakrabarti, Amlan Ghosh, Chinmay Kumar Panda
The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status
S. Connor, C. Sit, M. Anjari, M. Lei, T. Guerrero-Urbano, T. Szyszko, G. Cook, P. Bassett, V. Goh
Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review
Rishi Raj, Ghada Elshimy, Aasems Jacob, P. V. Akhila Arya, Dileep C. Unnikrishnan, Riccardo Correa, Zin W. Myint
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)
Tanja Holzhey, Wolfram Pönisch, Song-Yau Wang, Madlen Holzvogt, Bruno Holzvogt, Marc Andrea, Thomas Zehrfeld, Doreen Hammerschmidt, Franz Albert Hoffmann, Cornelia Becker, Andreas Schwarzer, Maik Schwarz, Uta Schönfelder-Fricke, Thomas Edelmann, Leanthe Braunert, Georg-Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Markus Bill, Juliane Grimm, Yvonne Remane, Uwe Platzbecker, Markus Scholz
Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care
Eran Ben-Arye, Dana Elly, Noah Samuels, Orit Gressel, Katerina Shulman, Elad Schiff, Ofer Lavie, Amir Minerbi
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
Eike Steidl, Katharina Filipski, Pia S. Zeiner, Marlies Wagner, Emmanouil Fokas, Marie-Therese Forster, Michael W. Ronellenfitsch, Iris Divé, Joachim P. Steinbach, Patrick N. Harter, Oliver Bähr
Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis
Hiroyuki Ohnuma, Yasushi Sato, Naoki Onoyama, Kota Hamaguchi, Naotaka Hayasaka, Masanori Sato, Kazuyuki Murase, Kohichi Takada, Koji Miyanishi, Takeshi Murakami, Tatsuya Ito, Takayuki Nobuoka, Ichiro Takemasa, Junji Kato
Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer
Mingxiang Feng, Xin Ye, Baishen Chen, Juncheng Zhang, Miao Lin, Haining Zhou, Meng Huang, Yanci Chen, Yunhe Zhu, Botao Xiao, Chuoji Huang, Ruth L. Katz, Chunxue Bai
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials
Wanting Hou, Mingfu Ding, Xiaohua Li, Xiaohan Zhou, Qing Zhu, Armando Varela-Ramirez, Cheng Yi
Is the prediction of one or two ipsilateral positive lymph nodes by computerized tomography and ultrasound reliable enough to restrict therapeutic neck dissection in oral squamous cell carcinoma (OSCC) patients?
Karl Christoph Sproll, Sabina Leydag, Henrik Holtmann, Lara K. Schorn, Joel Aissa, Patric Kröpil, Wolfgang Kaisers, Csaba Tóth, Jörg Handschel, Julian Lommen
Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma
Jung Ho Im, Gi Hong Choi, Woo Jung Lee, Dai Hoon Han, Seung Woo Park, Seungmin Bang, Hye Jin Choi, Jinsil Seong
Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study
Prashanth Ashok Kumar, Shweta Paulraj, Dongliang Wang, Danning Huang, Abirami Sivapiragasam
Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05
Ji Hyun Park, Gun Lyung You, Myung-Ju Ahn, Sang-We Kim, Min Hee Hong, Ji-Youn Han, Chan-Young Ock, Jong-Seok Lee, In Jae Oh, Shin Yup Lee, Cheol Hyeon Kim, Young Joo Min, Yoon Hee Choi, Jeong-Seon Ryu, Sun Hyo Park, Hee Kyung Ahn, Byoung-Yong Shim, Ki Hyeong Lee, Sung Yong Lee, Jin-Soo Kim, Jiun Yi, Su Kyung Choi, Hyonggin An, Jin Hyoung Kang
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
Cyrill Wehling, Michael T. Dill, Alexander Olkus, Christoph Springfeld, De-Hua Chang, Patrick Naumann, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Uta Merle, Jan Pfeiffenberger, Christian Rupp, Karl Heinz Weiss, Markus Mieth
A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H
Peng Li, Feng Hou, Sai Wang, Ningning Luo, Yingxue Qi, Yongjie Wang
Correction to: Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
Jordan Lerner-Ellis, Chloe Mighton, Conxi Lazaro, Nicholas Watkins, Vanessa Di Gioacchino, Andrew Wong, Martin C. Chang, George S. Charames